| abstract |
The present invention relates to vesicles derived from bacteria belonging to the genus Sphingomonas and compositions as well as uses thereof. In some embodiments, the composition is a drug carrier which delivers a drug to the brain. In some embodiments, the invention provides a method of suppressing the secretion inflammatory mediators by pathogenic vesicles using said vesicles derived from bacteria belonging to the genus Sphingomonas or compositions thereof. In some embodiments, the invention provides methods of diagnosing hepatic cirrhosis, liver cancer, myocardial infarction, renal insufficiency, diabetes, brain tumors, mild cognitive impairment, dementia, depression, autism, and/or atopic dermatitis. |